GAM Holding AG - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 952 filers reported holding BAXTER INTL INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
GAM Holding AG ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2019$237,000
-84.3%
2,835
-83.6%
0.01%
-83.6%
Q3 2019$1,511,000
-5.7%
17,272
-11.7%
0.07%
+6.3%
Q2 2019$1,603,000
+55.5%
19,571
+54.3%
0.06%
+46.5%
Q1 2019$1,031,000
+38.2%
12,684
+12.0%
0.04%
+13.2%
Q4 2018$746,000
+234.5%
11,327
+290.3%
0.04%
+375.0%
Q3 2018$223,000
-6.3%
2,902
-9.8%
0.01%0.0%
Q2 2018$238,000
-86.8%
3,217
-88.4%
0.01%
-87.3%
Q1 2018$1,799,000
-66.5%
27,665
-66.7%
0.06%
-61.6%
Q4 2017$5,363,000
+165.0%
82,971
+148.2%
0.16%
+446.7%
Q2 2017$2,024,000
-47.8%
33,427
-55.3%
0.03%
-50.8%
Q1 2017$3,881,000
+16.0%
74,844
-0.8%
0.06%
+3.4%
Q4 2016$3,346,000
-49.3%
75,472
-45.6%
0.06%
-49.1%
Q3 2016$6,600,000
-25.2%
138,654
-29.0%
0.12%
-15.3%
Q2 2016$8,829,000
+5.1%
195,235
-4.5%
0.14%
-2.1%
Q1 2016$8,401,000
-1.2%
204,487
-8.3%
0.14%
+6.1%
Q4 2015$8,503,000
+5.5%
222,897
-9.1%
0.13%
-4.3%
Q3 2015$8,056,000
-40.8%
245,234
+26.0%
0.14%
-29.9%
Q2 2015$13,614,000
-6.1%
194,675
-8.0%
0.20%
-9.2%
Q1 2015$14,502,000
-4.5%
211,708
+2.2%
0.22%
-4.4%
Q4 2014$15,189,000
-16.7%
207,233
-18.4%
0.23%
-14.3%
Q3 2014$18,237,000
-4.5%
254,103
-3.8%
0.26%
-8.6%
Q2 2014$19,102,000
-0.8%
264,194
+0.9%
0.29%
-6.1%
Q1 2014$19,261,000
-4.3%
261,735
-9.6%
0.31%
-12.0%
Q4 2013$20,126,000
+3.9%
289,433
-1.8%
0.35%
-3.3%
Q3 2013$19,367,000
-7.1%
294,833
-2.1%
0.36%
-20.4%
Q2 2013$20,856,000301,0730.46%
Other shareholders
BAXTER INTL INC shareholders Q1 2017
NameSharesValueWeighting ↓
Third Point 41,000,000$2,482,140,00022.00%
THUNDERBIRD PARTNERS LLP 1,711,643$103,623,00012.17%
SECTOR GAMMA AS 1,070,333$64,798,0009.42%
Veritas Asset Management LLP 10,179,102$616,243,0004.81%
13D Management LLC 194,807$11,794,0004.18%
Progressive Investment Management Corp 78,316$4,741,0003.69%
Aristotle Capital Management, LLC 6,846,307$414,476,0003.46%
ARGENT CAPITAL MANAGEMENT LLC 1,394,075$84,397,0003.37%
Lipe & Dalton 80,073$4,848,0003.14%
PURA VIDA INVESTMENTS, LLC 125,000$7,568,0003.00%
View complete list of BAXTER INTL INC shareholders